RMTG (Regenerative Medical Technology Group) Change In Receivables: $-0.07 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Regenerative Medical Technology Group Change In Receivables?

Regenerative Medical Technology Group RMTG +5.26% Change In Receivables is $-0.07 Mil as of Jun. 2026. The stock has 3 warning signs investors should review.

Regenerative Medical Technology Group's change in receivables for the quarter that ended in Jun. 2026 was $-0.08 Mil. It means Regenerative Medical Technology Group's Accounts Receivable increased by $0.08 Mil from Mar. 2026 to Jun. 2026 .

Regenerative Medical Technology Group's change in receivables for the fiscal year that ended in Dec. 2025 was $-0.02 Mil. It means Regenerative Medical Technology Group's Accounts Receivable increased by $0.02 Mil from Dec. 2024 to Dec. 2025 .

Regenerative Medical Technology Group's Accounts Receivable for the quarter that ended in Jun. 2026 was $0.11 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Regenerative Medical Technology Group's Days Sales Outstanding for the three months ended in Jun. 2026 was 2.50.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Regenerative Medical Technology Group's liquidation value for the three months ended in Jun. 2026 was $-43.46 Mil.

Regenerative Medical Technology Group  (OTCPK:RMTG) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Regenerative Medical Technology Group's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.11/4.023*91
=2.50

2. In Ben Graham's calculation of liquidation value, Regenerative Medical Technology Group's accounts receivable are only considered to be worth 75% of book value:

Regenerative Medical Technology Group's liquidation value for the quarter that ended in Jun. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1.323-45.106+0.75 * 0.11+0.5 * 0.481
=-43.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regenerative Medical Technology Group Change In Receivables Related Terms

Regenerative Medical Technology Group Change In Receivables Historical Data

* Premium members only.

The historical data trend for Regenerative Medical Technology Group's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regenerative Medical Technology Group Change In Receivables Chart

Regenerative Medical Technology Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only -0.00 -0.03 0.03 0.00 -0.02

Regenerative Medical Technology Group Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.08 0.07 0.01 -0.08

Regenerative Medical Technology Group Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $-0.07 Mil mean?
Regenerative Medical Technology Group (RMTG) has a Change In Receivables of $-0.07 Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Regenerative Medical Technology Group and its competitors.
Is Regenerative Medical Technology Group's Change In Receivables too high?
Regenerative Medical Technology Group's current Change In Receivables is $-0.07 Mil.
How does Regenerative Medical Technology Group's Change In Receivables compare to ABPO and CLSDQ?
Regenerative Medical Technology Group's Change In Receivables of $-0.07 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Biotechnology company?
A good Change In Receivables depends on the Biotechnology industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Regenerative Medical Technology Group and its competitors. Regenerative Medical Technology Group's current Change In Receivables is $-0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regenerative Medical Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Regenerative Medical Technology Group (RMTG) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.08, compared to a current price of $0.10 — trading 25% above its estimated fair value. The current Change In Receivables is $-0.07 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Regenerative Medical Technology Group (RMTG), the current Change In Receivables is $-0.07 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regenerative Medical Technology Group Business Description

Address 433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432
Regenerative Medical Technology Group Inc is engaged in the regenerative medicine business through its subsidiary, Global Stem Cells Group. The company provides stem cell therapies, exosomes, peptides, biologics, physician training and certifications, diagnostic tools, and related clinical support services. It operates through one reportable segment, Global Stem Cells Group.